Titlebook: Digital Strategies in the Pharmaceutical Industry; Leonard Lerer,Mike Piper Book 2003 Palgrave Macmillan, a division of Macmillan Publishe

時(shí)代

Digital strategies in research and development (R&D)g on R&D has increased from less than 10 per cent of sales in 1970 to approximately 20 per cent in 2000 [21, 23], and overall R&D spending has tripled since 1990 (Figure 5.1). The industry estimates that each approved drug must return between $300 million and $600 million to cover the cost of the failures [22].

2否定

Book 2003tical guide for managers planning, developing and implementing e-strategies in the pharmaceutical industry. The authors provide numerous examples of innovative, best practice and lay the strategic foundation for using e-business across the pharmaceutical value chain from drug discovery to physician

SEEK

白楊

蛙鳴聲

Thomas H. Maugh II,Jean L. Marxrugs approved for use in that particular institution) and providers and payers may reach a contractual agreement with the manufacturer to allow a drug (sold at a discount) to be prescribed and reimbursed.

尊敬

Thomas H. Maugh II,Jean L. Marxof detailing visits to physicians rose by only 15 per cent, as doctors succumbed to ‘salesperson fatigue’ [95]. The competitive environment demands that pharmaceutical companies continue the sales force arms race in the absence of viable alternatives.

archenemy

影響深遠(yuǎn)

Digital strategies in pharmaceutical distributionprice of a drug may be high, it generally costs very little to produce (this is certainly changing in terms of innovative biotechnology products) and it was not generally in a manufacturer’s interest to become too deeply enmeshed in the distribution chain (Figure 7.1).

易發(fā)怒

Cubicle

Digital strategies in marketing to the physicianof detailing visits to physicians rose by only 15 per cent, as doctors succumbed to ‘salesperson fatigue’ [95]. The competitive environment demands that pharmaceutical companies continue the sales force arms race in the absence of viable alternatives.